13F Pro quality score
Rank #738 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from LivaNova PLC's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $1.4B | $-242.5M | 14.4% |
| FY 2024 | 10-K | $1.3B | $63.2M | 10.3% |
| FY 2023 | 10-K | $1.2B | $17.5M | -5.9% |
| FY 2022 | 10-K | $1.0B | $-86.2M | -7.5% |
| FY 2021 | 10-K | $1.0B | $-135.8M | -0.1% |
| FY 2020 | 10-K | $934.2M | $-348.8M | -29.3% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
LivaNova PLC (LIVN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LIVN at 62.0/100 on a composite quality score built from its SEC filings, placing it at rank #738 of 2,925 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), LivaNova PLC reports quarterly revenue of $390.6M, net income of $108.6M, an operating margin of 12.7%. Top institutional holders of LIVN by reported 13-F value include BlackRock, PRIMECAP MANAGEMENT, FMR, based on the most recent SEC filings. LIVN trades on the Nasdaq exchange and files with the SEC under CIK 1639691. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LIVN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LivaNova PLC directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1639691 →